title: A microRNA signature for a BMP2-induced osteoblast lineage commitment program.
abstract: Bone morphogenetic proteins (BMPs) are potent morphogens that activate transcriptional programs for lineage determination. How BMP induction of a phenotype is coordinated with microRNAs (miRNAs) that inhibit biological pathways to control cell differentiation, remains unknown. Here, we show by profiling miRNAs during BMP2 induced osteogenesis of C2C12 mesenchymal cells, that 22 of 25 miRNAs which significantly changed in response to BMP2 are down-regulated. These miRNAs are each predicted to target components of multiple osteogenic pathways. We characterize two representative miRNAs and show that miR-133 directly targets Runx2, an early BMP response gene essential for bone formation, and miR-135 targets Smad5, a key transducer of the BMP2 osteogenic signal, controlled through their 3'UTR sequences. Both miRNAs functionally inhibit differentiation of osteoprogenitors by attenuating Runx2 and Smad5 pathways that synergistically contribute to bone formation. Although miR-133 is known to promote MEF-2-dependent myogenesis, we have identified a second complementary function to inhibit Runx2-mediated osteogenesis. Our key finding is that BMP2 controls bone cell determination by inducing miRNAs that target muscle genes but mainly by down-regulating multiple miRNAs that constitute an osteogenic program, thereby releasing from inhibition pathway components required for cell lineage commitment. Thus, our studies establish a mechanism for BMP morphogens to selectively induce a tissue-specific phenotype and suppress alternative lineages.
authors.affiliation: Department of Cell Biology and Cancer Center, University of Massachusetts Medical School, Worcester, MA 01655, USA.
authors.forename: Zhaoyong
authors.initials: Z
authors.lastname: Li
authors.forename: Mohammad Q
authors.initials: MQ
authors.lastname: Hassan
authors.forename: Stefano
authors.initials: S
authors.lastname: Volinia
authors.forename: Andre J
authors.initials: AJ
authors.lastname: van Wijnen
authors.forename: Janet L
authors.initials: JL
authors.lastname: Stein
authors.forename: Carlo M
authors.initials: CM
authors.lastname: Croce
authors.forename: Jane B
authors.initials: JB
authors.lastname: Lian
authors.forename: Gary S
authors.initials: GS
authors.lastname: Stein
mesh_terms: D000818:Animals; D001483:Base Sequence; D015415:Biomarkers; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000235:genetics / Q000378:metabolism*; D002454:Cell Differentiation; D002460:Cell Line; D019070:Cell Lineage; D050659:Core Binding Factor Alpha 1 Subunit / Q000235:genetics / Q000378:metabolism; D015536:Down-Regulation; D051379:Mice; D035683:MicroRNAs / Q000235:genetics*; D009132:Muscles / Q000378:metabolism; D010006:Osteoblasts / Q000166:cytology* / Q000378:metabolism*; D010641:Phenotype; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000378:metabolism*
chemical_list: D015415:Biomarkers; C525719:Bmp2 protein, mouse; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D050659:Core Binding Factor Alpha 1 Subunit; D035683:MicroRNAs; D016212:Transforming Growth Factor beta
references.citation: Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8721-6
references.pmid: 16731620
references.citation: J Clin Invest. 2007 Sep;117(9):2369-76
references.pmid: 17786230
references.citation: Oncogene. 2002 Oct 17;21(47):7156-63
references.pmid: 12370805
references.citation: J Cell Physiol. 2005 Jul;204(1):63-72
references.pmid: 15573378
references.citation: Trends Genet. 2008 Apr;24(4):159-66
references.pmid: 18325627
references.citation: N Engl J Med. 2008 Jan 31;358(5):502-11
references.pmid: 18234754
references.citation: Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):31-6
references.pmid: 11134512
references.citation: J Cell Biol. 1983 Jan;96(1):191-8
references.pmid: 6826647
references.citation: Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9740-4
references.pmid: 15210942
references.citation: Nature. 2007 Oct 11;449(7163):682-8
references.pmid: 17898713
references.citation: J Cell Biol. 1994 Dec;127(6 Pt 1):1755-66
references.pmid: 7798324
references.citation: Rev Endocr Metab Disord. 2006 Jun;7(1-2):1-16
references.pmid: 17051438
references.citation: J Biol Chem. 2006 Dec 29;281(52):40515-26
references.pmid: 17060321
references.citation: Mol Cell Biol. 2007 May;27(9):3337-52
references.pmid: 17325044
references.citation: Anat Sci Int. 2005 Mar;80(1):12-8
references.pmid: 15794126
references.citation: Nature. 2008 Jan 17;451(7176):340-4
references.pmid: 18202659
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):1949-54
references.pmid: 18238902
references.citation: J Biol Chem. 2003 Nov 14;278(46):45969-77
references.pmid: 12925529
references.citation: Mol Cell Biol. 2000 Dec;20(23):8783-92
references.pmid: 11073979
references.citation: J Biol Chem. 2005 Sep 30;280(39):33132-40
references.pmid: 16043491
references.citation: J Cell Biochem. 2003 May 15;89(2):401-26
references.pmid: 12704803
references.citation: PLoS Genet. 2006 Dec;2(12):e216
references.pmid: 17194222
references.citation: Nat Rev Mol Cell Biol. 2008 Mar;9(3):219-30
references.pmid: 18270516
references.citation: Trends Biochem Sci. 2007 Apr;32(4):189-97
references.pmid: 17350266
references.citation: Cancer Res. 1999 Aug 1;59(15):3705-11
references.pmid: 10446985
references.citation: Rev Endocr Metab Disord. 2006 Jun;7(1-2):33-9
references.pmid: 16960757
references.citation: Genes Dev. 2008 Feb 15;22(4):543-57
references.pmid: 18281466
references.citation: Endocrinology. 1997 Sep;138(9):3666-76
references.pmid: 9275051
references.citation: Nat Genet. 2006 Feb;38(2):228-33
references.pmid: 16380711
references.citation: Ann N Y Acad Sci. 2007 Nov;1116:29-49
references.pmid: 18083919
references.citation: J Biol Chem. 2008 Mar 28;283(13):8412-22
references.pmid: 18204048
references.citation: Nature. 2004 Sep 16;431(7006):343-9
references.pmid: 15372041
references.citation: J Cell Biol. 2007 Feb 26;176(5):709-18
references.pmid: 17325210